X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1345) 1345
transplantation (1039) 1039
hematology (1013) 1013
index medicus (992) 992
male (840) 840
female (828) 828
adult (760) 760
middle aged (683) 683
immunology (648) 648
bone-marrow-transplantation (636) 636
oncology (614) 614
transplantation, homologous (610) 610
stem cells (582) 582
hematopoietic stem cells (576) 576
adolescent (491) 491
versus-host-disease (425) 425
hematopoietic stem cell transplantation - adverse effects (416) 416
aged (363) 363
risk factors (351) 351
hematopoietic stem cell transplantation (338) 338
treatment outcome (329) 329
retrospective studies (328) 328
child (303) 303
stem-cell transplantation (302) 302
young adult (302) 302
health aspects (297) 297
allogeneic transplantation (283) 283
hematology, oncology and palliative medicine (276) 276
hematopoietic stem cell transplantation - methods (264) 264
allogeneic stem cell transplantation (261) 261
care and treatment (245) 245
transplantation conditioning - methods (236) 236
allogeneic hematopoietic stem cell transplantation (235) 235
leukemia (231) 231
mortality (215) 215
child, preschool (209) 209
stem cell transplantation (202) 202
cancer (199) 199
graft vs host disease - etiology (196) 196
graft vs host disease - prevention & control (186) 186
research (185) 185
medicine & public health (181) 181
analysis (178) 178
bone marrow (176) 176
recipients (172) 172
allogeneic (168) 168
survival analysis (165) 165
hematologic neoplasms - therapy (162) 162
recurrence (158) 158
graft-versus-host disease (156) 156
chemotherapy (155) 155
follow-up studies (154) 154
transplants & implants (151) 151
complications and side effects (148) 148
disease-free survival (148) 148
immunotherapy (144) 144
transplantation conditioning (142) 142
children (141) 141
incidence (140) 140
survival rate (138) 138
prognosis (133) 133
t cells (133) 133
acute myeloid-leukemia (132) 132
bone marrow transplantation (125) 125
therapy (123) 123
infant (122) 122
risk-factors (122) 122
chronic disease (120) 120
survival (120) 120
article (119) 119
pediatrics (118) 118
blood (116) 116
unrelated donors (114) 114
total-body irradiation (113) 113
transplantation, homologous - adverse effects (113) 113
disease (112) 112
graft vs host disease - immunology (112) 112
diagnosis (110) 110
time factors (110) 110
patient outcomes (107) 107
graft vs host disease - mortality (105) 105
allogeneic hematopoietic cell transplantation (102) 102
prevention (102) 102
transplantation conditioning - adverse effects (101) 101
bone-marrow transplantation (99) 99
acute disease (97) 97
animals (96) 96
relapse (93) 93
immunosuppressive agents - therapeutic use (92) 92
prospective studies (92) 92
risk (89) 89
gvhd (88) 88
graft versus host reaction (87) 87
infection (87) 87
cytomegalovirus (86) 86
hematologic malignancies (85) 85
bone marrow transplantation - adverse effects (84) 84
immune reconstitution (83) 83
infectious diseases (81) 81
leukemia, myeloid, acute - therapy (81) 81
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1673) 1673
French (10) 10
German (5) 5
Polish (2) 2
Russian (2) 2
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hematology/Oncology and Stem Cell Therapy, ISSN 1658-3876, 2017, Volume 10, Issue 4, pp. 220 - 227
Abstract The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT) survivors continues to increase. Among patients whose disease... 
Hematology, Oncology and Palliative Medicine | Allogeneic | Prevention | Autologous | Late effects | Hematopoietic cell transplantation | Late complications | Allogeneic: Late complications
Journal Article
2013, ISBN 111847337X, 416
Currently more than 100,000 patients undergo blood and marrow transplantation (BMT) annually worldwide, a number which is steadily increasing. Long-term... 
Hematology | Disease-Free Survival | Bone marrow | Hematopoietic stem cells
eBook
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2007, Volume 13, Issue 7, pp. 749 - 759
Abstract Pulmonary dysfunction is a significant complication following allogeneic hematopoietic stem cell transplantation (HSCT), and is associated with... 
Hematology, Oncology and Palliative Medicine | Allogeneic | Bronchiolitis obliterans organizing pneumonia (BOOP) | Bronchiolitis obliterans syndrome (BOS) | Pathogenesis | Diagnostic criteria | Late-onset noninfectious pulmonary complications | EXTRACORPOREAL PHOTOCHEMOTHERAPY | AZITHROMYCIN THERAPY | late-onset noninfectious pulmonary complications | diagnostic criteria | RISK-FACTORS | VENOOCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | IMMUNOLOGY | CYTOLYTIC THROMBI | VERSUS-HOST-DISEASE | TRANSPLANTATION | pathogenesis | LUNG TRANSPLANTATION | IDIOPATHIC PNEUMONIA | allogeneic | HEMATOLOGY | bronchiolitis obliterans syndrome (BOS) | bronchiolitis obliterans organizing pneumonia (BOOP) | AIR-FLOW OBSTRUCTION | Bronchiolitis Obliterans - etiology | Humans | Bronchiolitis Obliterans - mortality | Clinical Trials as Topic | Cryptogenic Organizing Pneumonia - mortality | Cryptogenic Organizing Pneumonia - therapy | Syndrome | Transplantation, Homologous | Bronchiolitis Obliterans - diagnosis | Cryptogenic Organizing Pneumonia - diagnosis | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Bronchiolitis Obliterans - therapy | Cryptogenic Organizing Pneumonia - etiology | Bronchiolitis Obliterans - pathology | Cryptogenic Organizing Pneumonia - pathology | Complications and side effects | Pneumonia | Transplantation | Bacterial pneumonia | Hematopoietic stem cells | Bronchiolitis
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 04/2018, Volume 24, Issue 4, pp. 734 - 740
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 05/2017, Volume 23, Issue 5, pp. 726 - 735
Fanconi anemia (FA), dyskeratosis congenita (DC), and Diamond Blackfan anemia (DBA) are 3 of the most common inherited bone marrow failure syndromes (IBMFS),... 
Pediatric allogeneic hematopoietic cell transplantation | Late effects | Dyskeratosis congenita | Fanconi anemia | Diamond Blackfan anemia | Inherited bone marrow failure syndromes | OXIDATIVE STRESS | 4 DECADES | INTENSITY CONDITIONING REGIMEN | IMMUNOLOGY | BIALLELIC MUTATIONS | FANCONI-ANEMIA | CHILDREN | TRANSPLANTATION | DYSKERATOSIS-CONGENITA | DISEASE | DIAMOND-BLACKFAN ANEMIA | HEMATOLOGY | APLASTIC-ANEMIA | Bone Marrow Diseases - complications | Fanconi Anemia - complications | Practice Guidelines as Topic - standards | Humans | Biomedical Research - trends | Forecasting | Anemia, Aplastic - therapy | Dyskeratosis Congenita - complications | Bone Marrow Diseases - therapy | Dyskeratosis Congenita - therapy | Long Term Adverse Effects | Hematopoietic Stem Cell Transplantation - adverse effects | Anemia, Diamond-Blackfan - therapy | Biomedical Research - methods | Fanconi Anemia - therapy | Hematopoietic Stem Cell Transplantation - methods | Hemoglobinuria, Paroxysmal - therapy | Anemia, Diamond-Blackfan - complications | Anemia, Aplastic - complications | Child | Hemoglobinuria, Paroxysmal - complications | Pediatrics | Conferences, meetings and seminars | Immunodeficiency | Bone marrow | Genetic aspects | Transplantation | Medical screening | Conferences and conventions | Hematopoietic stem cells | Fanconi's anemia | Medical research | Medicine, Experimental
Journal Article
Annals of Hematology, ISSN 0939-5555, 12/2012, Volume 91, Issue 12, pp. 1953 - 1958
Large pericardial effusion (LPE) with cardiac tamponade is a rare but life-threatening complication in adults undergoing hematopoietic stem cell... 
Medicine & Public Health | Hematology | Cardiac tamponade | Oncology | Graft-versus-host disease (GVHD) | Allogeneic hematopoietic stem cell transplantation (HSCT) | Pericardial effusion | Graftversus-host disease(GVHD) | RECIPIENT | BONE-MARROW-TRANSPLANTATION | CARDIAC-TAMPONADE | VERSUS-HOST-DISEASE | CHEMOTHERAPY | Graft-versus-host disease(GVHD) | PLEURAL EFFUSION | MINOR HISTOCOMPATIBILITY ANTIGENS | ACUTE LYMPHOBLASTIC-LEUKEMIA | HEMATOLOGY | CONSTRICTIVE PERICARDITIS | MANIFESTATIONS | Graft vs Host Disease - epidemiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Transplantation, Autologous | Transplantation, Homologous | Incidence | Time Factors | Pericardial Effusion - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Severity of Illness Index | Sjogren's Syndrome - etiology | Pericardiocentesis | Pericardial Effusion - physiopathology | Pericardial Effusion - epidemiology | Graft vs Host Disease - physiopathology | Taiwan - epidemiology | Graft vs Host Disease - prevention & control | Pericardial Effusion - etiology | Cardiac Tamponade - etiology | Hospitals, Veterans | Complications and side effects | Cyclophosphamide | Immunotherapy | Cardiac patients | Transplantation | Adults | Universities and colleges | Hematopoietic stem cells | Index Medicus
Journal Article
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 03/2012, Volume 47, Issue 3, pp. 337 - 341
Journal Article
Macedonian Journal of Medical Sciences, ISSN 1857-5749, 06/2017, Volume 5, Issue 3, pp. 340 - 343
Allogeneic hematopoietic stem cells transplantation (HSCT) is a curative intervention in patients with haematological malignant and non-malignant diseases,... 
Graft versus host disease | Secondary malignancy | Early and late complications | Allogeneic hematopoietic stem cells transplantation | case report | early and late complications | allogeneic transplantation
Journal Article